申请人:Sandoz Ltd.
公开号:US04755534A1
公开(公告)日:1988-07-05
A compound of the formula: ##STR1## wherein the double bond is in the trans configuration and R.sub.1 is a radical of formula IIa, ##STR2## R.sub.2, R.sub.3, R.sub.5, R.sub.7 and R.sub.8 are each hydrogen, R.sub.4 is methyl, and R.sub.6 is a radical of formula IIIa --C.tbd.C--R.sub.11 IIIa where R.sub.11 is n-butyl, tertiary butyl or phenyl or a chemotherapeutically acceptable acid addition salt thereof; processes for their production, their use as pharmaceuticals and pharmaceutical compositions containing them.
一种化合物的化学式:##STR1## 其中双键处于反式构型,R.sub.1是化学式IIa的基团,##STR2## R.sub.2、R.sub.3、R.sub.5、R.sub.7和R.sub.8分别为氢,R.sub.4为甲基,R.sub.6是化学式IIIa的基团--C.tbd.C--R.sub.11 IIIa,其中R.sub.11为正丁基、叔丁基或苯基,或其化疗可接受的酸盐;它们的生产过程,作为药物的用途,以及含有它们的药物组合物。